**Core tip:** There are many studies that compared totally laparoscopic total gastrectomy (TLTG) with laparoscopic-assisted total gastrectomy (LATG). Moreover, various modified methods of intracorporeal esophagojejunostomy have been presented, but standardized methods have not been established. Our results show that TLTG by esophagojejunostomy intracorporeal anastomosis using linear stapler is an easier and more straightforward procedure compared with LATG by extracorporeal anastomosis using circular stapler.

INTRODUCTION
============

Asian countries, especially South Korea and Japan, have the highest incidences of gastric cancer in the world\[[@B1]\]. Gastric cancer is the second most common cause of cancer-related deaths worldwide\[[@B2],[@B3]\], and surgery is the only curative modality for primary treatment of resectable gastric cancer\[[@B4],[@B5]\]. The proportion of early gastric cancer patients has increased in Korea and Japan as a result of improved nationwide surveillance\[[@B6],[@B7]\], and now accounts for nearly 60% of all cases. The incidence of upper and middle body gastric cancer has also increased. Consequently, the demand for minimally invasive treatments for upper body early gastric cancer has grown, and there is more need for new therapeutic methods and modalities. Laparoscopic gastrectomy has become one of the most popular modalities because of less postoperative pain, rapid postoperative recovery, lower blood loss, better cosmetic outcomes, and fewer complications compared with open gastrectomy\[[@B5],[@B8]-[@B10]\]. In addition, the oncologic outcomes of laparoscopic gastrectomy for gastric cancer are acceptable as well\[[@B11],[@B12]\].

Intracorporeal anastomosis has advantages over extracorporeal anastomosis because the former creates a smaller wound, provides a larger workspace and is less invasive\[[@B13]-[@B19]\]. Totally laparoscopic total gastrectomy (TLTG) using various types of intracorporeal anastomosis methods has been developed due to improvements in surgical devices and the accumulation of operative experience, but an optimal method for TLTG is yet to be established because of the technical challenges, especially for reconstruction of the esophagojejunostomy (EJ). Since 2008, TLTG using endoscopic linear staplers has been performed in our institute on more than 400 patients by expert surgeons with much experience of laparoscopic surgery, and we have developed a secure and effective technique for reconstructing the EJ\[[@B15]-[@B17]\].

In this study, we aimed to evaluate the surgical safety and efficacy of TLTG for treating gastric cancer of the upper third of the stomach by comparing its outcomes with those of laparoscopic-assisted total gastrectomy (LATG) using a circular stapler.

MATERIALS AND METHODS
=====================

Patients
--------

We reviewed the retrospectively collected data of 687 consecutive patients who underwent total gastrectomy by LATG (266 patients) and TLTG (421 patients), for gastric cancer in the upper and middle stomach, between August 2008 and August 2014 at Asan Medical Center in Seoul, South Korea. The diagnosis was based on preoperative examinations including esophagogastroduodenoscopy, endoscopic ultrasound (EUS), and computed tomography (CT). Patients with gastric cancer were selected by preoperative diagnostic test under T3N2M0 according to the American Joint Committee on Cancer (AJCC) - International Union for Cancer Control (UICC) 7^th^ edition\[[@B20]\]. Based on operative findings, patients with serosa-exposed advanced gastric cancer were converted to open surgery and were not included in this study. All patients were managed by clinical pathway after surgery\[[@B21]\]. The study was approved by the Institutional Review Board of Asan Medical Center.

Surgical techniques
-------------------

Partial omentectomy with either D1+ or D2 lymphadenectomy for early gastric cancer and total omentectomy with either D2 lymphadenectomy for advanced gastric cancer were performed using an ultrasonic scalpel according to the treatment guidelines published by the Japanese Gastric Cancer Association\[[@B22]\]. EJ was performed with a circular stapler (DST EEA^TM^ 25 single use stapler with 3.5 staples; Covidien, North Haven, CT, United States) via mini-laparotomy in LATG and with an endoscopic linear stapler (Endo GIA^TM^ 60 mm and 45 mm Articulating Medium/Thick Reload with Tri-Staple^TM^ Technology; Covidien) in TLTG (Figure [1](#F1){ref-type="fig"}). Finally, defects in the transmesentery and transcolon were closed *via* suturing. Details of the technique of TLTG have been described previously\[[@B16],[@B17]\]. In case of advanced gastric cancer or with spleen hilar lymph node swelling, hilar lymph node was harvested and intraoperative frozen biopsy was carried out. If the frozen biopsy result was positive, then splenectomy was also carried out.

![Forming an esophagojejunostomy. A: Nearly two-thirds of the esophagus diameter is transected 2 cm above the gastroesophageal junction using an endoscopic linear stapler; B: The first intracorporeal suture is made at the end of the staple line of the esophageal stump; C: The unstapled esophagus is transected with laparoscopic scissors after the remnant stomach has been clipped with manual titanium clips to avoid spillage of cancer cells; D: The second and third intracorporeal sutures are made at the esophagostomy site of the esophageal stump; E: To create an esophagojejunostomy, an endoscopic linear stapler is inserted by the operator between the esophagostomy and enterostomy of the jejunum. At this time the first assistant retracts the first thread towards the operator's direction inside the abdominal cavity, and the second assistant retracts the second thread through the right lower trocar from the outside of the abdomen; F: After an esophagojejunostomy has been constructed, the entry hole is held with tress suturing to approximate the tissue; G: The remnant entry hole is closed by the operator with an endoscopic linear stapler; H: An esophagojejunal anastomosis after completion of the reconstruction.](WJG-23-8553-g001){#F1}

Clinical analysis of surgical outcomes
--------------------------------------

Data obtained from medical records included patient age, sex, body mass index (BMI), American Society of Anesthesiologist (ASA) score, history of previous abdominal surgery, operative time, pre- and postoperative hematocrit, time to first flatus, day of commencement of soft diet, pain score by visual analogue scale, number of analgesics administered, intra- and postoperative transfusion, intraoperative events, postoperative hospital stay, tumor size, number of retrieved lymph nodes, resection margins and cancer stage according to the AJCC/UICC 7^th^ edition. Intraoperative events included jejunojejunostomy site kicking or narrowing, emphysema, and injury to organs such as pancreas, spleen, colon, small bowel, liver and major vessels. Intraoperative anastomosis events-related EJ refers to all unexpected events related to the EJ anastomosis, such as leakage after anastomosis, small bowel or esophagus injury caused by small diameter, pseudo-lumen stapling, sticking together of the crus muscle, *etc*.

Postoperative pain control consisted of intravenous, patient-controlled analgesia (fentanyl 2500 µg, ketorolac tromethamine 180 mg, and ondansetron hydrochloride 16 mg) and intermittent analgesic infusions. The amount of postoperative pain was assessed by visual analogue scale and by the number of additional doses of analgesics required until hospital discharge. A postoperative complication was defined as any event that required conservative or surgical treatment after surgery. Early complications were defined as events occurring within 30 d, and late complications as those occurring after 30 d. These complications were examined and classified by the Clavien-Dindo system\[[@B23]\].

Statistical analysis
--------------------

Statistical analyses were performed with SPSS v18.0. Categorical variables were compared using the chi-square test or Fisher's exact test. All continuous variables were analyzed using the Mann-Whitney test, the *t*-test or the chi-square test, depending on the data. A *P-*value of less than 0.05 was considered statistically significant.

RESULTS
=======

Clinical features and pathological characteristics
--------------------------------------------------

The clinical characteristics of the LATG and TLTG groups are presented in Table [1](#T1){ref-type="table"}. The LATG and TLTG groups consisted of 266 and 421 patients, respectively. Their mean ages at the time of operation were 55.69 ± 11.96 years and 57.78 ± 11.20 years, respectively (*P* = 0.020). There were no significant differences between the two groups for sex (*P* = 0.583), ASA score (*P* = 0.064) or BMI (*P* = 0.883). Frequencies of abdominal surgery were 12.4% and 20.2% (*P* = 0.008) in LATG and TLTG groups, respectively. In summary, the TLTG group was slightly older and had more histories of abdominal surgery than LATG group.

###### 

Clinical characteristics of patients who underwent laparoscopic-assisted total gastrectomy and totally laparoscopic total gastrectomy

  **Variable**                   **LATG, n = 266**   **TLTG, *n* = 421**   ***P* value**
  ------------------------------ ------------------- --------------------- ---------------
  Age in years, mean ± SD        55.69 ± 11.96       57.78 ± 11.20         0.020
  Sex                                                                      0.583
  Male                           167 (62.8)          273 (64.8)            
  Female                         99 (37.2)           148 (35.2)            
  ASA score                                                                0.064
  I                              181 (68.0)          249 (59.1)            
  II                             68 (25.6)           145 (34.4)            
  III                            17 (6.4)            27 (6.4)              
  BMI in kg/m^2^                                                           0.883
  \< 23                          119 (44.7)          198 (47.0)            
  ≥ 23, \< 25                    70 (26.3)           103 (24.5)            
  ≥ 25, \< 30                    69 (25.9)           110 (26.1)            
  ≥ 30                           8 (3.0)             10 (2.4)              
  History of abdominal surgery   33 (12.4)           85 (20.2)             0.008

Values are expressed as mean ± SD or *n* (%). ASA: American Society of Anesthesiologists physical status classification; BMI: Body mass index; LATG: Laparoscopic-assisted total gastrectomy; TLTG: Totally laparoscopic total gastrectomy.

Table [2](#T2){ref-type="table"} presents the pathologic results for the LATG and TLTG groups. The mean numbers of retrieved lymph nodes were 34.91 ± 13.92 and 40.04 ± 15.59 in the LATG and TLTG groups, respectively, indicating that lymph node dissection was adequate in both groups. The remaining pathological characteristics did not differ significantly between the groups, except for proximal resection margin length (LATG: 3.85 ± 3.11 cm and TLTG: 2.68 ± 2.62 cm, *P* \< 0.001).

###### 

Pathologic results of the laparoscopic-assisted total gastrectomy and totally laparoscopic total gastrectomy groups

  **Variable**                  **LATG, *n* = 266**   **TLTG, *n* = 421**   ***P* value**
  ----------------------------- --------------------- --------------------- ---------------
  Tumor size in cm              3.72 ± 2.47           3.95 ± 2.90           0.302
  Retrieved lymph nodes, *n*    34.91 ± 13.92         40.04 ± 15.59         \< 0.001
  metastatic lymph nodes, *n*   0.63 ± 2.59           0.82 ± 3.20           0.421
  Proximal margin in cm         3.85 ± 3.11           2.68 ± 2.62           \< 0.001
  Distal margin in cm           12.72 ± 4.86          12.79 ± 4.67          0.870
  TNM (AJCC/UICC) staging                                                   0.395
  IA                            202 (75.9)            285 (67.7)            
  IB                            26 (9.8)              52 (12.4)             
  IIA                           19 (7.1)              40 (9.5)              
  IIB                           8 (3.0)               22 (5.2)              
  IIIA                          5 (1.9)               8 (1.9)               
  IIIB                          4 (1.5)               11 (2.6)              
  IIIC                          2 (0.8)               3 (0.7)               

Values are expressed as mean ± SD or *n* (%). AJCC/UICC: 7^th^ edition of the American Joint Committee on Cancer staging - Union for International Cancer Control; LATG: Laparoscopic-assisted total gastrectomy; TLTG: Totally laparoscopic total gastrectomy.

Surgical outcomes and postoperative clinical course
---------------------------------------------------

Table [3](#T3){ref-type="table"} shows the early surgical outcomes. There were significant differences in operation time (LATG: 170 (range, 65-453) min and TLTG: 149 (range, 75-342) min, *P* \< 0.001), postoperative hematocrit change (LATG: 4.05% (range, -3.8%-15.2%) and TLTG: 3.50% (range, -4.9%-18.6%), *P* = 0.002), intraoperative events (LATG: 27 cases (10.2%) and TLTG: 13 cases (3.1%), *P* \< 0.001), and intraoperative anastomosis events related to EJ (LATG: 19 cases (7.1%) and TLTG: 10 cases (2.4%), *P* \< 0.001). There were no significant differences in postoperative transfusions, combined operations, pain scores or administration of analgesics. Combined operations were appendectomy, cholecystectomy, distal pancreatectomy and splenectomy, *etc*. There were three splenectomy cases in the TLTG group. Splenectomy was carried out in two cases in order to control splenic bleeding and in one case because of metastasis found in splenic hilar lymph node biopsy. However, the median time to first flatus \[LATG: 3.60 (range, 1-7) d and TLTG: 3.30 (range, 1-7) d, *P* \< 0.001\] and to median commencement of soft diet (LATG: 4.61 (range, 2-68) d and TLTG: 4.30 (range, 3-36) d, *P* \< 0.001), as well as length of post-operative hospital stay \[LATG: 7.02 (range, 5-1117) and TLTG: 6.75 (range, 4-82), *P* = 0.005\] were significantly longer in LATG than in TLTG.

###### 

Early surgical outcomes in patients undergoing laparoscopic-assisted total gastrectomy and totally laparoscopic total gastrectomy

  **Variables**                                         **LATG, *n* = 266**   **TLTG, *n* = 421**   ***P* value**
  ----------------------------------------------------- --------------------- --------------------- ---------------
  Operation time in min                                 170 (65-453)          149 (75-342)          \< 0.001
  Hematocrit change in (%)                              4.04 (-3.8-15.2)      3.49 (-4.9-18.6)      0.002
  Intra-operative transfusion                           1 (0.4)               1 (0.2)               1.000
  Post operative transfusion                            28 (10.5)             55 (13.1)             0.32
  Intra-operative event                                 27 (10.2)             13 (3.1)              \< 0.001
  Intra-operative anastomosis event                     19 (7.1)              10 (2.4)              0.003
  Combined operation                                    17 (6.4)              27 (6.4)              1.000
  Time to first flatus in d (range)                     3.60 (1-7)            3.30 (1-7)            \< 0.001
  Time to soft diet in d (range)                        4.61 (2-68)           4.30 (3-36)           \< 0.001
  Pick of pain score, score (range)                     7.11 (2-10)           6.96 (3-10)           0.912
  8AM Pain socre of POD \#1, score (range)              3.45 (0-10)           3.49 (0-10)           0.841
  8AM Pain socre of POD \#3, score (range)              2.44 (0-9)            2.54 (0-7)            0.529
  8AM Pain socre of POD \#5, score (range)              1.75 (0-10)           1.51 (0-8)            0.055
  Number of administration of analgesics, *n* (range)   2.49 (0-69)           2.86 (0-67)           0.131
  Post-operative hospital stay in d (range)             7.02 (5-1117)         6.75 (4-82)           0.005

Values are expressed as median (range) or *n* (%). Hematocrit change means the difference between preoperative hematocrit and postoperative hematocrit. LATG: Laparoscopic-assisted total gastrectomy; POD: Postoperative days; TLTG: Totally laparoscopic total gastrectomy.

Postoperative complications
---------------------------

Early and late postoperative complications are presented in Table [4](#T4){ref-type="table"}. There was no significant difference in Clavien-Dindo classification between the groups. Overall, early postoperative complications were observed in 53 (19.9%) patients in the LATG group and 87 (20.7%) in the TLTG group (*P* = 0.447). There were 21 (7.9%) and 37 (8.8%) overall late postoperative complications in the LATG and TLTG groups, respectively (*P* = 0.681). In addition, the occurrence rate of EJ-related early complications, such as leakage, did not significantly differ between the two groups (LATG: 14 cases (5.3%) and TLTG: 14 cases (3.3%), *P* = 0.211). Late complications related to EJ were also similar in the two groups (LATG: 4 cases (0.9%) and TLTG: cases (0.7%), *P* = 0.439). The classes of the postoperative complications are given in Table [4](#T4){ref-type="table"}, and the types of complications, including bleeding, leakage, stricture, intraabdominal fluid collection, internal hernia, ileus and wound infection, are presented in Table [5](#T5){ref-type="table"}. Early complications following TLTG classified as Clavien-Dindo classification grade ≥ III were observed in 85 (8.3%) patients, and late complications classified as Clavien-Dindo classification grade ≥ III were observed in 18 (4.3%) patients.

###### 

Early and late postoperative complications *n* (%)

              **Early complications**   **Late complications**                                     
  ----------- ------------------------- ------------------------ ------- ------------ ------------ -------
  CDC                                                            0.447                             0.681
  0           213 (80.1)                334 (79.3)                       245 (92.1)   384 (91.2)   
  1           24 (9.0)                  26 (6.2)                         10 (3.8)     15 (3.6)     
  2           13 (4.9)                  26 (6.2)                         0 (0)        4 (1.0)      
  3           12 (4.5)                  33 (7.8)                         11 (4.1)     18 (4.3)     
  4           4 (1.5)                   2 (0.5)                          0 (0)        0 (0)        
  Cx of EJ                                                       0.211                             0.439
  None        252 (94.7)                407 (96.7)                       262 (98.5)   418 (99.3)   
  Leakage     14 (5.3)                  14 (3.3)                         1 (0.4)      1 (0.2)      
  Stricture   0 (0.0)                   0 (0.0)                          3 (1.1)      2 (0.5)      

Values are expressed as *n* (%). CDC: Clavien-Dindo classification; Cx: Complications; EJ: Esophagojejunostomy; LATG: Laparoscopic-assisted total gastrectomy; TLTG: Totally laparoscopic total gastrectomy.

###### 

Postoperative complications in patients who underwent laparoscopic-assisted total gastrectomy and totally laparoscopic total gastrectomy *n* (%)

                                    **LATG, *n* = 266**   **TLTG, *n* = 421**
  --------------------------------- --------------------- ---------------------
  Bleeding                          4 (1.50)              8 (1.90)
  EJ leakage                        15 (5.64)             15 (3.56)
  EJ stricture                      3 (1.13)              2 (0.48)
  Intraabdominal fluid collection   8 (3.01)              26 (6.18)
  Internal hernia                   5 (1.88)              12 (2.85)
  Mechanical ileus                  10 (3.76)             28 (6.65)
  Paralytic ileus                   3 (1.13)              7 (1.66)
  Wound infection                   18 (6.77)             9 (2.14)
  Other surgical complications      4 (1.50)              8 (1.90)
  Medical complications             4 (1.50)              2 (0.48)

EJ: Esophagojejunostomy; LATG: Laparoscopic-assisted total gastrectomy; TLTG: Totally laparoscopic total gastrectomy.

DISCUSSION
==========

Various modified methods of TLTG have been developed, but no standard method for upper and middle gastric cancer has been established because the reconstruction of intracorporeal EJs requires a high level of technical proficiency and is difficult, even for experienced surgeons\[[@B24]-[@B28]\]. We have recently reported a TLTG method developed for intracorporeal EJ using an endoscopic linear stapler, and we believe that it could become a standard method for these patients\[[@B16],[@B17]\]. Although extracorporeal EJ anastomosis using a circular stapler is the generally accepted method for laparoscopic total gastrectomy, the anastomosis is often difficult to complete because of the limited working space formed by the mini-laparotomy\[[@B24]\]. Furthermore, an extended laparotomy incision is sometimes required, but this may reduce the benefits of the laparoscopic approach.

In a study on distal gastrectomy, TLTG without a mini-laparotomy was unaffected by obesity and could, thus, be a safe procedure for avoiding the impact of obesity\[[@B18],[@B19]\]. Similarly, TLTG helps the surgeon easily resect and reconstruct the anastomosis without limiting the surgeon's view. In a previous study, TLTG produced similar early surgical outcomes to LATG, although the BMI was higher in the TLTG group\[[@B29]\]. In the present retrospective study, the TLTG patients had similar BMIs and tended to be slightly older, with more histories of abdominal surgery compared with LATG patients. Nevertheless, TLTG was superior to LATG in terms of operation time, postoperative hematocrit change, intraoperative events, bowel movements, and postoperative hospital stays. Although TLTG is less invasive than LATG, there was no significant difference in pain score, which was probably due to the use of active pain control, such as patient-controlled analgesia.

Chen et al\[[@B5]\] found in their meta-analysis that the number of lymph nodes harvested in TLTG was marginally higher than in LATG (*P* = 0.06). In our study, lymphadenectomy seems to have been adequate in both groups, despite the significant difference in the number of retrieved lymph nodes in the LATG and TLTG group (34.91 ± 13.92 and 40.04 ± 15.59, respectively, *P* \< 0.001). The reason for this difference is unclear since the lymphadenectomy procedure is the same in both LATG and TLTG. There was a significant difference between the LATG and TLTG groups with regard to the length of the resection margin (LATG: 3.85 ± 3.11 cm and TLTG: 2.68 ± 2.62 cm, *P* \< 0.001). This could be attributed to the fact that linear staplers are often placed on either side of the resection line, and might hinder accurate histopathologic evaluation of the surgical margin of the resected specimen. Linear staplers generally have four or six rows of staples and form two or three staple lines on a margin of length approximately 4-5 mm as exempted staples on the resection line, in contrast to conventional circular staplers\[[@B30]\]. Moreover, the linear staplers used in TLTG require a substantial length of esophagus for anastomosis. On the other hand, the circular stapler used in LATG allows the esophagus to be transected more proximally and does not need a long esophageal stump. EJ anastomosis using a circular stapler, thus, allows higher anastomosis in patients with tumors at the gastroesophageal junction, or in the upper stomach and invading the esophagus\[[@B31],[@B32]\].

In the current study, the TLTG group was older and had more histories of abdominal surgery. However, the operation time for TLTG was shorter than for LATG. Our TLTG experience suggests several factors that may contribute to this shorter operation time. First, TLTG provides a wider view than LATG. Second, reconstruction in TLTG carried out with a linear stapler is easy, rapid and requires no hand-sewn reinforcement procedure. Finally, opening and closing a mini-laparotomy is not required. Incision for a mini-laparotomy may take especially long additional incision in obese patients. Moreover, our data show that TLTG has superior surgical outcomes in terms of postoperative hematocrit change, intraoperative events, time to first flatus, soft diet and postoperative hospital stay because the intracorporeal method has a wider view and causes less surgical trauma.

Postoperative morbidity after LATG has been reported to range from 17% to 27%\[[@B33]-[@B38]\]. In our study, early complication occurring within 30 d following LATG and TLTG classified as Clavien-Dindo classification grade ≥ III were observed in 16 (6.0%) and 35 (8.3%) patients, respectively; late complications developing after 30 d following LATG and TLTG were observed in 11 (4.1%) and 18 (4.3%) patients, respectively. These results show that there were no significant differences between LATG and TLTG in terms of postoperative complications.

Patient characteristics such as age and obesity are risk factors for postoperative complications in laparoscopic gastrectomy. ASA scores may be influenced by age and comorbidity because these factors reinforce each other. Most of all, being overweight is a potent risk factor for poor surgical outcomes\[[@B39],[@B40]\]. Delayed bowel movement, increased postoperative pain, and prolonged hospital stay can occur in obese patients, as we have suggested in a previous report on laparoscopic distal gastrectomy\[[@B40]\]. We found no significant differences in early and late complications between LATG and TLTG, even though the TLTG group patients were much older and had more histories of abdominal surgery. In addition, there was no significant difference between the two groups in complications related to EJ. However, TLTG makes a wide operating space and carries out EJ construction safely, and several investigators have insisted that the anastomotic site should be further secured and have a wider diameter when using a linear stapler than when using a circular stapler\[[@B5],[@B16],[@B41]\].

The procedure of LATG and TLTG differ in many ways. First, TLTG is less invasive, and requires a smaller incision than does LATG. Second, the wider working space in TLTG ensures safe reconstruction of the EJ. Therefore, laparoscopic surgeons are more comfortable with the intracorporeal than the extracorporeal one. Furthermore, using a linear stapler in TLTG has another advantage in that whereas circular staplers have only two staggered rows, endoscopic linear staplers have three staggered rows and provide better staple line security.

We conclude that TLTG requires a shorter operation time and permits faster postoperative recovery than LATG, while having similar surgical outcomes and complications. Therefore, TLTG using a linear stapler may be considered a more appropriate procedure than LATG using a circular stapler, and may be recommended for the treatment of gastric cancer of the upper third of the stomach.

This study has certain limitations. It is a retrospective study from a single institution and the baseline clinical characteristic of the two groups were different. Although the pathologic results for the patients in the LATG and TLTG groups were similar, the LATG and TLTG operations were performed at different periods of time. In addition, cancer recurrence and long-term survival rates were not analyzed because approximately half the patients underwent surgery, and 5 years had not yet passed. Therefore, data on long-term outcomes are still needed in order to compare the oncological adequacy of these two methods.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

In Korea and Japan, the incidence of upper and middle body gastric cancer has increased as a result of improved nationwide surveillance. Furthermore, the indication of laparoscopic gastrectomy has also extended. Therefore, the demand for minimally invasive surgery for upper body gastric cancer has grown, and there is more need for new therapeutic methods and modalities.

Research motivation
-------------------

Intracorporeal anastomosis and extracorporeal anastomosis in laparoscopic total gastrectomy has developed due to improvements in surgical devices and the accumulation of operative experience, but an optimal method for laparoscopic total gastrectomy has yet to be established due to the difficulties of esophagojejunostomy.

Research objectives
-------------------

We aimed to evaluate the surgical safety and efficacy of intracorporeal anastomosis using linear stapler for treating gastric cancer of the upper third of the stomach by comparing its outcomes with those of extracorporeal anastomosis using circular stapler.

Research methods
----------------

From August 2008 to August 2014, 687 consecutive patients who underwent total gastrectomy (266 laparoscopic-assisted total gastrectomy (LATG) patients and 421 totally laparoscopic total gastrectomy (TLTG) patients) were reviewed retrospectively. Data obtained from medical records included patient age, sex, body mass index, American Society of Anesthesiologist score, history of abdominal surgery, operative time, pre- and postoperative hematocrit, time to first flatus, day of commencement of soft diet, pain score by visual analogue scale, number of analgesics administered, intra- and postoperative transfusion, intraoperative events, postoperative hospital stay, tumor size, number of retrieved lymph nodes, resection margins and cancer stage according to the American Joint Committee on Cancer - International Union for Cancer Control 7^th^ edition.

Research results
----------------

The TLTG group had higher mean age at time of operation, and more histories of abdominal surgery. However, the TLTG group required a shorter operation time, lower postoperative hematocrit change, less intraoperative events, less intraoperative anastomosis events, and permitted faster postoperative recovery, such as median time to first flatus, median commencement of soft diet and length of postoperative hospital stay.

Research conclusions
--------------------

TLTG may be considered a feasible procedure, as compared to LATG. Because TLTG provides a wider view than TLTG, reconstruction in TLTG carried out with a linear stapler is easy, rapid and requires no hand-sewn reinforcement procedure, and TLTG does not need additional mini-laparotomy. Furthermore, TLTG had superior surgical outcomes in terms of operation time, postoperative hematocrit change, intraoperative events and postoperative recovery.

Research perspectives
---------------------

Based on our results, we can consider TLTG as a feasible and straightforward procedure. But this study has certain limitations. It is a retrospective study from a single institution, and although the pathologic results in the LATG and TLTG groups were similar, data on long-term outcomes are still needed to compare the oncological adequacy of these two methods.
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